In conclusion, we demonstrated that propofol inhibits the stemness and EMT of colon cancer cells by downregulating the SIRT1 and the Wnt/β-catenin and AKT/mTOR signaling pathways. This evidence concerns the gene SIRT1 and colonic neoplasm.